4.6 Article

Assessment of Albumin ECM Accumulation and Inflammation as Novel In Vivo Diagnostic Targets for Multi-Target MR Imaging

Journal

BIOLOGY-BASEL
Volume 10, Issue 10, Pages -

Publisher

MDPI
DOI: 10.3390/biology10100964

Keywords

serum albumin; extracellular matrix; macrophages; atherosclerosis; magnetic resonance imaging

Categories

Funding

  1. Deutsche Forschungs gemeinschaft (DFG, German Research Foundation) [372486779-SFB 1340/1 2018, MA 5943/3-1/4-1/9-1, BHF (RG/12/1/29262)]

Ask authors/readers for more resources

The study investigated the feasibility of using MRI probes to simultaneously assess ECM-associated intraplaque albumin deposits and inflammation in atherosclerosis, revealing significant correlations between MRI signals and plaque characteristics. Multi-target MRI combining different probes shows promise in improving diagnosis and treatment monitoring in atherosclerosis.
Atherosclerosis is a progressive inflammatory vascular disease characterized by endothelial dysfunction and plaque burden. Extracellular matrix (ECM)-associated plasma proteins play an important role in disease development. Our magnetic resonance imaging (MRI) study investigates the feasibility of using two different molecular MRI probes for the simultaneous assessment of ECM-associated intraplaque albumin deposits caused by endothelial damage and progressive inflammation in atherosclerosis. Male apolipoprotein E-deficient (ApoE(-/-))-mice were fed a high-fat diet (HFD) for 2 or 4 months. Another ApoE(-/-)-group was treated with pravastatin and received a HFD for 4 months. T1- and T2*-weighted MRI was performed before and after albumin-specific MRI probe (gadofosveset) administration and a macrophage-specific contrast agent (ferumoxytol). Thereafter, laser ablation inductively coupled plasma mass spectrometry and histology were performed. With advancing atherosclerosis, albumin-based MRI signal enhancement and ferumoxytol-induced signal loss areas in T2*-weighted MRI increased. Significant correlations between contrast-to-noise-ratio (CNR) post-gadofosveset and albumin stain (R-2 = 0.78, p < 0.05), and signal loss areas in T2*-weighted MRI with Perls' Prussian blue stain (R-2 = 0.83, p < 0.05) were observed. No interference of ferumoxytol with gadofosveset enhancement was detectable. Pravastatin led to decreased inflammation and intraplaque albumin. Multi-target MRI combining ferumoxytol and gadofosveset is a promising method to improve diagnosis and treatment monitoring in atherosclerosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available